ArticleFrontiers in immunology2023

Clinical markers predict the efficacy of several immune checkpoint inhibitors in patients with non-small cell lung cancer in China.

Yuxin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.